SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-05-002159
Filing Date
2005-03-09
Accepted
2005-03-09 17:21:43
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AMGEN INC.- DECEMBER 31, 2004 v06403e10vk.htm 10-K 1337000
2 EXHIBIT 10.14 v06403exv10w14.htm EX-10.14 2166
3 EXHIBIT 10.18 v06403exv10w18.htm EX-10.18 3038
4 EXHIBIT 10.52 v06403exv10w52.htm EX-10.52 9640
5 EXHIBIT 10.55 v06403exv10w55.htm EX-10.55 2727
6 EXHIBIT 21 v06403exv21.txt EX-21 924
7 EXHIBIT 31 v06403exv31.htm EX-31 16156
8 EXHIBIT 32 v06403exv32.htm EX-32 6483
  Complete submission text file 0000950129-05-002159.txt   1380611
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 05670150
SIC: 2836 Biological Products, (No Diagnostic Substances)